You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 華大基因漲停 全資子公司獲得三個新冠病毒檢測相關產品註冊證
格隆匯 02-03 11:24
格隆匯2月3日丨華大基因(300676.SZ)漲停,現報87.45元,暫成交19.3億元,最新總市值349.9億元。華大基因昨晚公佈,全資子公司獲得三個新型冠狀病毒檢測相關產品註冊證,其中兩款成為首批正式獲准上市的抗擊冠狀病毒疫情的檢測產品之一。此前1月26日晚間,上海之江生物科技、上海捷諾生物科技、華大基因和華大智造研發的2019新型冠狀病毒核酸檢測試劑盒獲得了國家藥監局的上市批准,這意味着檢測試劑盒拿到正式的批件,可以直接在醫院使用。此外據悉,國家藥監局曾公佈為包括華大集團(華大基因和華大智造)在內的7家新型冠狀病毒檢測試劑盒生產商開通快速審批通道;華大基因宣佈向武漢市捐贈一萬人份新型冠狀病毒檢測試劑盒。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account